Second transplant with twounrelatedcordbloodunitsforearlygraft failure after haemato poieticstemcell transplantation
ShortReport
G-CSF,shehadnomarrowrecoverywithamixedchima-erism(37%donor),leadingtothedecisiontoperformasecondtransplantation.ConditioningincludedCy,Fluandtotalbodyirradiation(TBI).Eighty-onedaysafterthe rsttransplant,shereceived2UCBunits,achievingengraftmentatD+27.AnacuteGvHD(aGvHD)grade-IIandlimitedcGvHDweretreatedwithsteroids.Sheisnow12monthsafterthesecondtransplantwithcompletedonorchimaerismofoneCBunit.
(Storbetal,1987;Ohwadaetal,2004).WedecidedtoperformasecondtransplantusinganRICinourpatientswithGF.Thefeasibilityofasecondtransplantalsodependsonarapidworkupforaseconddonor.Inthesesituations,CBiseasilyavailablewhencomparedwithotherunrelatedHSCTsourcesand,moreimportantly,theycanbeobtainedmorequickly.Barkeretal(2002)foundthatittookamedianof29moredaystoidentifyanunrelatedBMdonorthananUCBunit(Barkeretal,2002).Becauseoftheurgentsituationforthesefourpatients,amedianof15donlywastakenbetweenthedecisiontoperformasecondtransplantandthegraftinfusion.TocircumventthecelldoseproblemobservedwithasingleCBunit(Gluckmanetal,1997;Gluckmanetal,2004),weusedtwoCBunits.Inrecentyears,studiesconsideringtheuseoftwoCBunitshavebeenpublished,aimingtoincreasecelldosemainlyinadultpatientsandsoincreasingtheprobabilityofengraftment(Barkeretal,2005).Whethertransplantationof2UCBunitsimprovesengraftmentcomparedwithasingleunitisnotyetknown.Barkeretal(2005)showedinastudyof23patients,that21evaluablepatientsengraftedinamediantimeof23d,whichissigni cantlyhigherthanthereportedrateforsingleCBunits.RecentstudiesshowedthatstemcellsfrombothCBunitsinitiallycontributetoengraftmentbut,inthemajorityofcases(Weinrebetal,1998;Ohwadaetal,2004;Barkeretal,2005),engraftmentissustainedpredominantlybyjustoneunit,aswasalsofoundinourpatients.Themechanismsleadingthisphenomenonarenotwellelucidated,butsomeauthorssuggestthattheremaybeanimmunologicalmechanismfacilitatingthisprocess(Barkeretal,2005;Nautaetal,2005).Inconclusion,secondtransplantusingtwocordbloodunitsafterRICtotreatearlyGFseemstobeapromisingprocedure.
Patient3
A13-year-oldboy,diagnosedwithacutemyeloidleukaemia(AML)withmonosomy7,wasreferredforanUCBTaftermyeloablativeconditioning.AtD+19,atoxoplasmosisinfectionwasdiagnosedinvolvinglungsandbrain,andtreatedwithsulfadiazineandpyrimethamine.AtD+46,withnosignsofmyeloidrecovery,aBMaspiratecon rmedGF,andthedecisiontoperformasecondtransplantwastaken.FollowingconditioningwithCy,FluandATG,2UCBunitswereinfused75dafterthe rsttransplant.EngraftmentwasachievedonD+20,withcompletedonorchimaerism.AtD+40,hedevelopedgrade-IIaGVHD,whichwastreatedwithsteroids.Later,aCMVreactivationwascontrolledwithFoscarnet,andanextensivecGvHDrespondedtosteroids.Heisnow12monthsafterthesecondtransplant,inCRandwithfulldonorchimaerismofoneCBunit.
Patient4
A5-year-oldboyunderwentaUCBTforapromyelocyticleukaemiat(15;17)insecondCR.Consideringthehistoryofapreviousautologoustransplantandavenooclusivediseaseaftergentuzumab,areduced-intensityconditioning(RIC)wasgiven.AtD+12,heshowedanincreaseinlymphocytecounts,concomitanttoCMVinfection.Chimaerismper-formedthatdayshowed100%ofrecipientcells,conse-quentlyimmunosuppressionwasreducedandstopped.AtD+61,aBMaspiratecon rmedGF.DecisionwastakenforasecondHSCT,withconditioningwithFlu,CyandTBI.AtD+76afterthe rsttransplanthereceived2UCBunits.NeutrophilrecoverywasachievedatD+18,withfulldonorchimaerism.Concomitantly,hedevelopedgrade-IIaGVHD,withevolutiontoaGrade-IVaGVHD,complicatedbyanadenovirusinfection.Despiteallimmunosuppressiveandantiviraltreatment,hediedonD+46afterthesecondtransplant.
References
Barker,J.N.,Krepski,T.P.,DeFor,T.E.,Davies,S.M.,Wagner,J.E.&Weisdorf,D.J.(2002)Searchingforunrelateddonorhematopoieticstemcells:availabilityandspeedofumbilicalcordbloodversusbonemarrow.BiologyofBloodandMarrowTransplantation,8,257–260.
Barker,J.N.,Weisdorf,D.J.,DeFor,T.E.,Blazar,B.R.,McGlave,P.B.,Miller,J.S.,Verfaillie,C.M.&Wagner,J.E.(2005)Transplantationof2partiallyHLA-matchedumbilicalcordbloodunitstoenhanceengraftmentinadultswithhematologicmalignancy.Blood,105,1343–1347.
Davies,S.M.,Kollman,C.,Anasetti,C.,Antin,J.H.,Gajewski,J.,Casper,J.T.,Nademanee,A.,Noreen,H.,King,R.,Confer,D.&Kernan,N.A.(2000)Engraftmentandsurvivalafterunrelated-donorbonemarrowtransplantation:areportfromthenationalmarrowdonorprogram.Blood,96,4096–4102.
Gluckman,E.,Rocha,V.,Boyer-Chammard,A.,Locatelli,F.,Arcese,W.,Pasquini,R.,Ortega,J.,Souillet,G.,Ferreira,E.,Laporte,J.P.,Fernandez,M.&Chastang,C.(1997)Outcomeofcord-bloodtransplantationfromrelatedandunrelateddonors.EurocordTransplantGroupandtheEuropeanBloodandMarrowTrans-plantationGroup.NewEnglandJournalofMedicine,337,373–381.
Discussion
SecondallogeneictransplantsusingthesameoradifferentdonorarealternativetreatmentsforearlyGFforpatientsundergoingapreviousallogeneicHSCT.Althoughassociatedwithahightreatment-relatedmortality,studiesthatusedlessintenseconditioningregimenswereabletoreduceitstoxicity250
ª2007VandersonRocha
JournalCompilationª2007BlackwellPublishingLtd,BritishJournalofHaematology,137,248–251
Second transplant with two unrelated cord blood units for early graft failure after cord blood trans_临床医学_医药卫生_专业资料。Second transplant with two...
Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007; 137: 248–...
unrelated donors and cord blood units, HSCT is no longer limited only to ...second transplant with conditioning due to graft failure, patients expired ...
unrelated donors and cord blood units, HSCT is no longer limited only to ...second transplant with conditioning due to graft failure, patients expired ...
热门文档